other material
confidence high
sentiment neutral
materiality 0.60
Pasithea Therapeutics raises $5M in private placement of pre-funded warrants and Series A/B warrants
Pasithea Therapeutics Corp.
- Gross proceeds ~$5M; net proceeds ~$4.5M after fees and expenses.
- Issued 1,219,513 pre-funded warrants at $0.001 exercise, plus Series A and B warrants at $3.85 exercise; combined price $4.099 per unit.
- Series A warrants expire in 5 years, Series B warrants expire in 18 months.
- Proceeds for working capital and general corporate purposes; H.C. Wainwright acted as placement agent.
- Company agreed to file resale registration statement within 15 days; 90-day lock-up on further equity issuance.